Search Results - "Kumabashiri, I."

Role of tissue factor in disseminated intravascular coagulation by Asakura, H., Kamikubo, Y., Goto, A., Shiratori, Y., Yamazaki, M., Jokaji, H., Saito, M., Uotani, C., Kumabashiri, I., Morishita, E., Aoshima, K., Nakamura, S., Matsuda, T.

“…We examined plasma antigen levels of tissue factor (TF) in 95 cases of disseminated intravascular coagulation (DIC), to investigate the role of TF in DIC. A…”
Get full text

Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia by Ogawa, H, Fujimura, M, Matsuda, T, Nakamura, H, Kumabashiri, I, Kitagawa, S

“…The clinicopathologic features of five patients with acute eosinophilic pneumonia who presented with transient wheeze as well as acute onset of high fever,…”
Get more information

Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation by Asakura, H, Hifumi, S, Jokaji, H, Saito, M, Kumabashiri, I, Uotani, C, Morishita, E, Yamazaki, M, Shibata, K, Mizuhashi, K

“…It is well known that atrial fibrillation (AF) is one of the most important diseases that predispose patients to thrombosis. We have attempted to identify…”
Get more information

Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome by Yamazaki, M, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Aoshima, K, Ikeda, T, Matsuda, T

“…The mechanisms underlying clinical abnormalities associated with the antiphospholipid antibody syndrome (APAS) have not been elucidated. We measured plasma…”
Get more information

Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats by Yamazaki, M, Asakura, H, Aoshima, K, Saito, M, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Ikeda, T, Matsuda, T

“…We investigated the protective effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against two kinds of experimental…”
Get more information

Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Aoshima, K, Matsuda, T

“…Plasma levels of thrombin-antithrombin III complex (TAT), plasmin-alpha 2-plasmin inhibitor complex (PIC) and active plasminogen activator inhibitor (PAI) were…”
Get more information

Effects of aerosol administration of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to acetylcholine in asthmatic subjects by Fujimura, M, Nishioka, S, Kumabashiri, I, Matsuda, T, Mifune, J

“…Bronchial hyperresponsiveness is one of the major clinical features of bronchial asthma. We previously reported that oral administration of a selective…”
Get more information

Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis by Stehlik, Christian, de Martin, Rainer, Kumabashiri, Ichiro, Schmid, Johannes A., Binder, Bernd R., Lipp, Joachim

“…By differential screening of tumor necrosis factor α (TNF-α) and lipopolysaccharide (LPS)- activated endothelial cells (ECs), we have identified a cDNA clone…”
Get full text

Role of endothelin in disseminated intravascular coagulation by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…We examined the changes in plasma levels of endothelin-1 (ET-1), a potent vasoconstrictor peptide, in 47 cases of disseminated intravascular coagulation (DIC)…”
Get more information

Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy by Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Aoshima, K, Matsuda, T

“…The purpose of this pilot study was to determine the effect of recombinant hirudin (r-hirudin) on coagulopathy and the relationship between concentrations of…”
Get more information

Prothrombin Himi: A Compound Heterozygote for Two Dysfunctional Prothrombin Molecules (Met-337 → Thr and Arg-388 → His) by Morishita, Eriko, Saito, Masanori, Kumabashiri, Ichiro, Asakura, Hidesaku, Matsuda, Tamotsu, Yamaguchi, Kazuo

“…A congenitally dysfunctional form of prothrombin, Prothrombin Himi, shows reduced fibrinogen clotting activity, although it retains full hydrolytic activity…”
Get full text

Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine by Morishita, E, Nakao, S, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Yamazaki, M, Yoshida, T, Takemoto, K, Aoshima, K, Hashimoto, T, Matsuda, T

“…There is some clinical evidence that cyclosporine A (CyA) is associated with thrombotic complications of bone marrow and renal transplantation. We investigated…”
Get more information

Levels of Activated Factor VII in Patients With Disseminated Intravascular Coagulation by Saito, Masanori, Asakura, Hidesaku, Yoshida, Tomotaka, Jokaji, Hiroshi, Uotani, Chika, Kumabashiri, Ichiro, Morishita, Eriko, Yamazaki, Masahide, Aoshima, Keiji, Matsuda, Tamotsu

Get full text

Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration by Yamazaki, M, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Nakamura, S, Naito, T, Ohta, H

“…We report a 74-year-old Japanese woman who had bleeding due to a factor VIII inhibitor in the absence of diseases known to be associated with its development…”
Get more information

Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain by Uotani, C, Miyata, T, Kumabashiri, I, Asakura, H, Saito, M, Matsuda, T, Kajiyama, S, Iwanaga, S

“…Congenital dysfibrinogenaemia was found in a 39-year-old female and her two children. The proposita, apparently heterozygous for this abnormality, had no…”
Get more information

The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin? by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…Changes in thrombin-antithrombin III complex (TAT) over a one week period studied in 42 cases of disseminated intravascular coagulation (DIC); 19 treated with…”
Get more information

Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases by Saito, M, Morishita, E, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Yamazaki, M, Aoshima, K, Matsuda, T

“…We measured plasma levels of tissue factor (TF), total tissue factor pathway inhibitor (TFPI) and free TFPI antigen in patients with diabetes mellitus (DM),…”
Get more information

Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan by Kaya, H, Nakamura, S, Yamazaki, H, Kumabashiri, I, Ohtake, S, Matsuda, T

“…A 67-year-old woman was treated with MP-P therapy and combination chemotherapy for multiple myeloma IgG-lambda type. After the therapy for about three years,…”
Get more information

An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation by Asakura, Hidesaku, Ontachi, Yasuo, Mizutani, Tomoe, Kato, Minori, Saito, Masanori, Kumabashiri, Ichiro, Morishita, Eriko, Yamazaki, Masahide, Aoshima, Keiji, Nakao, Shinji

“…OBJECTIVESTo investigate the relationship between fibrinolytic enhancement and the development of multiple organ failure (MOF) in disseminated intravascular…”
Get full text

Plasma exchange failures in two patients with thrombotic thrombocytopenic purpura by Takamatsu, H, Kumabashiri, I, Machi, T, Saito, Y, Kitagawa, S, Ohtake, S, Matsuda, T

“…We treated two patients with thrombotic thrombocytopenic purpura (TTP) with multiple plasma exchanges for a short period. Following 6 plasma exchanges during…”
Get more information